Advanced search
Publication Cover
Journal of Chemotherapy Latest Articles
Submit an article Journal homepage
58
Views
0
CrossRef citations to date
0
Altmetric
Antimicrobial Original Research Paper

Daptomycin and ceftaroline combination for the treatment of persistent methicillin-resistant Staphylococcus aureus bloodstream infections: a case series and literature review

Yazed S. Alsowaidaa Department of Clinical Pharmacy, College of Pharmacy, Ha'il University, Ha'il, Saudi Arabia;b Division of Infectious Diseases, The Warren Alpert Medical School, Brown University, Providence, RI, USACorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0002-0450-9846View further author information
ORCID Icon,
Ahmed Alsolamic Department of Internal Medicine, College of Medicine, University of Ha'il, Ha'il, Saudi ArabiaView further author information
&
Thamer A. Almangourd Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi ArabiaView further author information
Received 02 Feb 2024, Accepted 05 Apr 2024, Published online: 12 Apr 2024

References

  • Geriak M, Haddad F, Rizvi K, et al. Clinical data on daptomycin plus ceftaroline versus standard of care monotherapy in the treatment of methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2019;63(5):10–1128. doi: 10.1128/AAC.02483-18.
  • Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):285–292. doi: 10.1093/cid/cir034.
  • Kitaya S, Kanamori H, Baba H, et al. Clinical and epidemiological characteristics of persistent bacteremia: a decadal observational study. Pathogens. 2023;12(2):212. doi: 10.3390/pathogens12020212.
  • Lewis PO, Heil EL, Covert KL, et al. Treatment strategies for persistent methicillin-resistant Staphylococcus aureus bacteraemia. J Clin Pharm Ther. 2018;43(5):614–625. doi: 10.1111/jcpt.12743.
  • Johnson TM, Molina KC, Miller MA, et al. Combination ceftaroline and daptomycin salvage therapy for complicated methicillin-resistant Staphylococcus aureus bacteraemia compared with standard of care. Int J Antimicrob Agents. 2021;57(4):106310. doi: 10.1016/j.ijantimicag.2021.106310.
  • McCreary EK, Kullar R, Geriak M, et al. Multicenter cohort of patients with Methicillin-Resistant Staphylococcus aureus bacteremia receiving daptomycin plus ceftaroline compared with other MRSA treatments. Open Forum Infect Dis. 2020;7(1):ofz538. doi: 10.1093/ofid/ofz538.
  • Zhang R, Barreras Beltran IA, Ashford NK, et al. Synergy between beta-lactams and lipo-, glyco-, and lipoglycopeptides, is independent of the seesaw effect in methicillin-resistant Staphylococcus aureus. Front Mol Biosci. 2021;8:688357. doi: 10.3389/fmolb.2021.688357.
  • Heidary M, Khosravi AD, Khoshnood S, et al. Daptomycin. J Antimicrob Chemother. 2018;73(1):1–11. doi: 10.1093/jac/dkx349.
  • Barber KE, Smith JR, Ireland CE, et al. Evaluation of ceftaroline alone and in combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with reduced susceptibility to daptomycin and vancomycin in an in vitro pharmacokinetic/pharmacodynamic model. Antimicrob Agents Chemother. 2015;59(8):4497–4503. doi: 10.1128/AAC.00386-15.
  • Henderson H, Luterbach CL, Cober E, et al. The Pitt bacteremia score predicts mortality in nonbacteremic infections. Clin Infect Dis. 2020;70(9):1826–1833. doi: 10.1093/cid/ciz528.
  • Patel D, Brown ML, Edwards S, et al. Outcomes of daptomycin plus ceftaroline versus alternative therapy for persistent methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia. Int J Antimicrob Agents. 2023;61(3):106735. doi: 10.1016/j.ijantimicag.2023.106735.
  • Alsowaida YS, Kubiak DW, Dionne B, et al. Vancomycin area under the concentration-time curve estimation using Bayesian modeling versus first-order pharmacokinetic equations: a quasi-experimental study. Antibiotics (Basel). 2022;11(9):1239. doi: 10.3390/antibiotics11091239.
  • Hornak JP, Anjum S, Reynoso D. Adjunctive ceftaroline in combination with daptomycin or vancomycin for complicated methicillin-resistant Staphylococcus aureus bacteremia after monotherapy failure. Ther Adv Infect Dis. 2019;6:2049936119886504. doi: 10.1177/2049936119886504.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.